November 20, 2026
Uncategorized

Ozempic patent expiry to trigger boom in weight-loss drugs in India (Soban News)

India is the first major country after Canada where Novo is losing patent on semaglutide and will see an onslaught of generic versions​India is the first major country after Canada where Novo is losing patent on semaglutide and will see an onslaught of generic versions ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Divi’s Labs slips 3% on margin worries; analysts positive on growth outlook (Soban News)

News-Soban-Admin

Oil prices fall as hopes for US-Iran deal outweigh supply concerns (Soban News)

News-Soban-Admin

Stay Healthy By Eating According To Your Blood Type

Soban

Leave a Comment